Wells Fargo & Company Armata Pharmaceuticals, Inc. Put Options Transaction History
Wells Fargo & Company
- $434 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ARMP
# of Institutions
27Shares Held
1.38MCall Options Held
400Put Options Held
17.3K-
Bank Of America Corp Charlotte, NC634KShares$1.49 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA225KShares$529,4240.0% of portfolio
-
Geode Capital Management, LLC Boston, MA107KShares$251,6050.0% of portfolio
-
Edgewood Management LLC Greenwich, CT100KShares$235,0000.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX75.4KShares$177,1470.0% of portfolio
About Armata Pharmaceuticals, Inc.
- Ticker ARMP
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,144,700
- Market Cap $84.9M
- Description
- Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus ...